Form 10-12G/A Eagle Point Trinity Seni
As filed with the Securities and Exchange Commission on December 5, 2025
File No. 000-56776
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10
(Amendment No. 2)
GENERAL FORM FOR REGISTRATION OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g)
OF THE SECURITIES EXCHANGE ACT OF 1934
Eagle Point Trinity Senior Secured Lending Company
(Exact name of registrant as specified in charter)
| Delaware | 99-2899518 |
| (State or other jurisdiction of incorporation or registration) |
(I.R.S. Employer Identification No.) |
| 600 Steamboat Road, Suite 202 Greenwich, CT |
06830 |
| (Address of principal executive offices) | (Zip Code) |
(203) 340-8500
(Registrant’s telephone number, including area code)
with copies to:
Harry S. Pangas, Esq.
Darius I. Ravangard, Esq.
Alexander C. Karampatsos, Esq.
Dechert LLP
1900 K St NW
Washington, DC 20006
Securities to be registered pursuant to Section 12(b) of the Act:
None
Securities to be registered pursuant to Section 12(g) of the Act:
Shares of beneficial interest
(Title of class)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ¨ | Accelerated filer | ¨ |
| Non-accelerated filer | x | Smaller reporting company | ¨ |
| Emerging growth company | x |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
TABLE OF CONTENTS
| EXPLANATORY NOTE | 1 | |
| ITEM 13. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA | 2 |
| ITEM 15. | FINANCIAL STATEMENTS AND EXHIBITS | 3 |
Eagle Point Trinity Senior Secured Lending Company (“we”, “us”, “our” or the “Fund”) is filing this second amendment (“Amendment No. 2”) to its registration statement on Form 10 (as amended, the “Registration Statement”), initially filed with the U.S. Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on August 28, 2025 and amended on October 27, 2025 (the “Prior Filing”), to include a report of the independent registered public accounting firm of the Fund with respect to the audited financial statements for the fiscal year ended December 31, 2024, which reflects such audit being conducted in accordance with the standards of the Public Company Accounting Oversight Board. In accordance with Rule 12b-15 under the Exchange Act, this Amendment No. 2 amends only Item 13 and Item 15 of Form 10.
The Registration Statement became effective automatically sixty days after it was initially filed with the SEC, and the Fund is currently subject to the reporting and other requirements of the Exchange Act and the rules promulgated thereunder.
This Amendment No. 2 should be read in conjunction with the Prior Filing and any subsequent filings of the Fund with the SEC.
1
| ITEM 13. | Financial Statements And Supplementary Data |
The following documents are being filed as part of this Registration Statement:
The following documents were included in the Prior Filing:
2
| ITEM 15. | Financial Statements And Exhibits |
(a) List separately all financial statements filed
The financial statements attached to this Registration Statement are listed under “Item 13. Financial Statements And Supplementary Data.”
(b) Exhibits
Exhibit Index
3
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized.
| EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY | ||
| By: | /s/ Kenneth P. Onorio | |
| Name: Kenneth P. Onorio | ||
| Title: Chief Financial Officer and Chief Accounting Officer | ||
Date: December 5, 2025
4
EPT 16 LLC
CONSOLIDATED FINANCIAL STATEMENTS
FOR THE PERIOD FROM JUNE 28, 2024 (COMMENCEMENT OF OPERATIONS) THROUGH
DECEMBER 31, 2024
F-1
EPT 16 LLC
Table of Contents
F-2
Report of Independent Registered Public Accounting Firm
To the Members of EPT 16 LLC
Opinion on the Financial Statements
We have audited the accompanying consolidated statement of assets and liabilities of EPT 16 LLC (the Fund), including the consolidated schedule of investments, as of December 31, 2024 , the related consolidated statements of operations, changes in members’ capital, and cash flows for the period from June 28, 2024 (commencement of operations) to December 31, 2024, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Fund at December 31, 2024, and the results of its operations, changes in its members’ capital, and its cash flows for the period from June 28, 2024 (commencement of operations) to December 31, 2024, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These financial statements are the responsibility of the Fund’s management. Our responsibility is to express an opinion on the Fund’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.
F-3
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of investments owned as of December 31, 2024, by correspondence with the underlying investee companies, borrowers and others; when replies were not received from the underlying investee companies, borrowers and others, we performed other auditing procedures. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
/s/ Ernst & Young LLP
We have served as the Fund’s auditor since 2024.
Los Angeles, California
December 5, 2025
F-4
EPT 16 LLC
Consolidated Statement of Assets, Liabilities, and Members’ Capital
(In thousands)
| December 31, 2024 | ||||
| ASSETS | ||||
| Non-Control/Non-Affiliate Investments at fair value (cost of $66,473) | $ | 66,886 | ||
| Cash and cash equivalents | 2,239 | |||
| Interest receivable | 726 | |||
| Deferred credit facility costs | 796 | |||
| Other assets | 6 | |||
| Total assets | $ | 70,653 | ||
| LIABILITIES | ||||
| KeyBank Credit Facility | $ | 12,400 | ||
| Management fees payable | 316 | |||
| Incentive fees payable | 185 | |||
| Contingent incentive fees payable | 132 | |||
| Interest payable | 140 | |||
| Security deposits | 525 | |||
| Accrued expenses and other liabilities | 650 | |||
| Total liabilities | 14,348 | |||
| Commitments and contingencies (Note 8) | ||||
| MEMBERS’ CAPITAL | ||||
| Members’ capital | 56,305 | |||
| Total members’ capital | 56,305 | |||
| Total Liabilities and Members’ Capital | $ | 70,653 | ||
See accompanying notes to consolidated financial statements.
F-5
EPT 16 LLC
Consolidated Statement of Operations
(In thousands)
| For the period from June | ||||
| 28, 2024 (commencement | ||||
| of operations) to | ||||
| December 31, 2024 | ||||
| INVESTMENT INCOME: | ||||
| Interest income from Non-Control/Non-Affiliate investments | $ | 2,632 | ||
| Fee income | 79 | |||
| Total investment income | 2,711 | |||
| EXPENSES: | ||||
| Origination fees | 739 | |||
| Management fees | 316 | |||
| Incentive fees | 185 | |||
| Contingent incentive fees | 132 | |||
| Organizational costs | 605 | |||
| Professional fees | 145 | |||
| Interest expense and other debt financing costs | 215 | |||
| Other expenses | 89 | |||
| Total expenses | 2,426 | |||
| NET INVESTMENT INCOME | 285 | |||
| Net realized gain from Non-Control/Non-Affiliate investments | 318 | |||
| Net unrealized appreciation from investments Non-Control/Non-Affiliate investments | 413 | |||
| NET INCREASE IN MEMBERS’ CAPITAL RESULTING FROM OPERATIONS | $ | 1,016 | ||
See accompanying notes to consolidated financial statements.
F-6
EPT 16 LLC
Consolidated Statement of Changes in Members’ Capital
(In thousands)
| Members’ Capital as of June 28, 2024 (Commencement of Operations) | — | |||
| Contributions | 55,289 | |||
| Net increase in members’ capital resulting from operations | 1,016 | |||
| Members’ Capital as of December 31, 2024 | $ | 56,305 |
See accompanying notes to consolidated financial statements.
F-7
EPT 16 LLC
Consolidated Statement of Cash Flows
(In thousands)
| For the period from | ||||
| June 28, 2024 | ||||
| (commencement of | ||||
| operations) to | ||||
| December 31, 2024 | ||||
| Cash flows provided by/(used in) operating activities: | ||||
| Net increase/(decrease) in members’ capital resulting from operations | $ | 1,016 | ||
| Adjustments to reconcile net increase/(decrease) in members’ capital resulting from operation to net cash provided by/(used in) operating activities: | ||||
| Net unrealized (appreciation)/depreciation from investments | (413 | ) | ||
| Net realized (gain)/loss from investments | (318 | ) | ||
| Accretion of original issue discount/premium on investments | (425 | ) | ||
| Amortization of deferred credit facility costs | 59 | |||
| Purchase of investments | (74,943 | ) | ||
| Proceeds from the sale and paydowns of investments | 9,213 | |||
| Change in operating assets and liabilities | ||||
| (Increase)/Decrease in interest receivable | (731 | ) | ||
| Increase/(Decrease) in security deposits | 525 | |||
| Increase/(Decrease) in accrued expenses and other liabilities | 650 | |||
| Increase/(Decrease) in management fees payable, incentive fees payable, and interest payable | 773 | |||
| Net cash provided by/(used in) operating activities | (64,594 | ) | ||
| Cash flows provided by/(used in) financing activities | ||||
| Contributions received | 55,289 | |||
| Borrowings under Credit Facility | 12,400 | |||
| Deferred credit facility costs paid | (856 | ) | ||
| Net cash provided by/(used in) financing activities | 66,833 | |||
| Net increase/(decrease) in cash and cash equivalents | 2,239 | |||
| Cash and cash equivalents at beginning of period | — | |||
| Cash and cash equivalents at end of period | $ | 2,239 | ||
| Supplemental and non-cash financing activities: | ||||
| Cash paid during the period for interest | $ | — | ||
See accompanying notes to consolidated financial statements.
F-8
EPT 16 LLC
Consolidated Schedule of Investments
December 31, 2024
(In thousands)
| Portfolio Company (1) | Type
of Investment (2) |
Maturity Date | Interest Rate (3) | Principal Amount (4) |
Cost | Fair Value (5) | Footnotes | |||||||||||||||
| Debt Securities- United States | ||||||||||||||||||||||
| Artificial Intelligence & Automation | ||||||||||||||||||||||
| Applied Digital Corporation | Equipment Financing | March 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | $ | 1,453 | $ | 1,460 | $ | 1,498 | |||||||||||||
| Equipment Financing | April 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | 773 | 777 | 798 | |||||||||||||||||
| Equipment Financing | April 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | 1,258 | 1,282 | 1,293 | |||||||||||||||||
| Total Applied Digital Corporation | $ | 3,484 | $ | 3,519 | $ | 3,589 | ||||||||||||||||
| Cirrascale Cloud Services, LLC | Equipment Financing | September 1, 2026 | Fixed interest rate 12.7%; EOT 4.9% | $ | 1,198 | $ | 1,236 | $ | 1,236 | |||||||||||||
| Equipment Financing | April 1, 2027 | Fixed interest rate 10.2%; EOT 5.2% | 1,266 | 1,273 | 1,273 | |||||||||||||||||
| Total Cirrascale Cloud Services, LLC | $ | 2,464 | $ | 2,509 | $ | 2,509 | ||||||||||||||||
| Augmented Reality Concepts, Inc. | Secured Loan | June 18, 2029 | Variable interest rate SOFR 3 Month Term + 4.3% or Floor rate 7.3%; EOT 0.0% | $ | 1,230 | $ | 1,227 | $ | 1,239 | (6) | ||||||||||||
| Sub-Total: Artificial Intelligence & Automation (13.0%)* | $ | 7,178 | $ | 7,255 | $ | 7,337 | ||||||||||||||||
| Connectivity | ||||||||||||||||||||||
| Tarana Wireless, Inc. | Secured Loan | October 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 12.5%; EOT 4.0% | $ | 1,200 | $ | 1,141 | $ | 1,158 | (6) | ||||||||||||
| Sub-Total: Connectivity (2.1%)* | $ | 1,200 | $ | 1,141 | $ | 1,158 | ||||||||||||||||
| Consumer Products & Services | ||||||||||||||||||||||
| Ogee, Inc. | Secured Loan | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | $ | 300 | $ | 302 | $ | 302 | (6) | ||||||||||||
| Secured Loan | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 300 | 303 | 303 | (6) | ||||||||||||||||
| Secured Loan | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 300 | 295 | 295 | (6) | ||||||||||||||||
| Total Ogee, Inc. | $ | 900 | $ | 900 | $ | 900 | ||||||||||||||||
| Sub-Total: Consumer Products & Services (1.6%)* | $ | 900 | $ | 900 | $ | 900 | ||||||||||||||||
F-9
EPT 16 LLC
Consolidated Schedule of Investments
December 31, 2024
(In thousands)
| Portfolio Company (1) | Type
of Investment (2) |
Maturity Date | Interest Rate (3) | Principal Amount (4) |
Cost | Fair Value (5) | Footnotes | |||||||||||||||
| Debt Securities- United States, Continued | ||||||||||||||||||||||
| Finance and Insurance | ||||||||||||||||||||||
| Beam Technologies, Inc. | Secured Loan | April 1, 2027 | Variable interest rate PRIME + 4.3% or Floor rate 11.0%+PIK Fixed Interest Rate 1.5%; EOT 2.0% | $ | 2,230 | $ | 2,187 | $ | 2,207 | (6)(7) | ||||||||||||
| Centivo Corporation | Secured Loan | August 1, 2029 | Variable interest rate PRIME + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | $ | 502 | $ | 493 | $ | 498 | (6)(7) | ||||||||||||
| Secured Loan | August 1, 2029 | Variable interest rate PRIME + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 500 | 471 | 470 | (6)(7) | ||||||||||||||||
| Total Centivo Corporation | $ | 1,002 | $ | 964 | $ | 968 | ||||||||||||||||
| Cherry Technologies, Inc. | Secured Loan | April 1, 2029 | Variable interest rate PRIME + 4.5% or Floor rate 12.0%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | $ | 535 | $ | 534 | $ | 544 | (6)(7) | ||||||||||||
| Secured Loan | April 1, 2029 | Variable interest rate PRIME + 4.5% or Floor rate 12.0%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 533 | 530 | 548 | (6)(7) | ||||||||||||||||
| Total Cherry Technologies, Inc. | $ | 1,068 | $ | 1,064 | $ | 1,092 | ||||||||||||||||
| Empower Financial, Inc. | Secured Loan | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | $ | 378 | $ | 386 | $ | 386 | (6) | ||||||||||||
| Secured Loan | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 98 | 95 | 97 | (6) | ||||||||||||||||
| Secured Loan | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 147 | 143 | 146 | (6) | ||||||||||||||||
| Secured Loan | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 152 | 144 | 146 | (6) | ||||||||||||||||
| Secured Loan | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 505 | 508 | 524 | (6) | ||||||||||||||||
| Total Empower Financial, Inc. | $ | 1,280 | $ | 1,276 | $ | 1,299 | ||||||||||||||||
| Gravie, Inc. | Secured Loan | July 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 13.0%; EOT 2.5% | $ | 1,020 | $ | 1,023 | $ | 1,008 | (6) | ||||||||||||
| Under Technologies, Inc. | Secured Loan | June 1, 2029 | Variable interest rate PRIME + 3.8% or Floor rate 12.0%; EOT 4.3% | $ | 600 | $ | 589 | $ | 598 | (6) | ||||||||||||
| Secured Loan | June 1, 2029 | Variable interest rate PRIME + 3.8% or Floor rate 12.0%; EOT 4.3% | 600 | 587 | 587 | (6) | ||||||||||||||||
| Total Under Technologies, Inc. | $ | 1,200 | $ | 1,176 | $ | 1,185 | ||||||||||||||||
| Wisetack, Inc. | Secured Loan | December 1, 2029 | Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 2.5% | $ | 900 | $ | 892 | $ | 892 | (6) | ||||||||||||
| Sub-Total: Finance and Insurance (15.4%)* | $ | 8,700 | $ | 8,582 | $ | 8,651 | ||||||||||||||||
| Food and Agriculture Technologies | ||||||||||||||||||||||
| DrinkPak, LLC | Equipment Financing | September 1, 2026 | Fixed interest rate 12.9%; EOT 10.5% | $ | 974 | $ | 1,070 | $ | 1,080 | |||||||||||||
| Sub-Total: Food and Agriculture Technologies (1.9%)* | $ | 974 | $ | 1,070 | $ | 1,080 | ||||||||||||||||
F-10
EPT 16 LLC
Consolidated Schedule of Investments
December 31, 2024
(In thousands)
| Portfolio Company (1) | Type
of Investment (2) |
Maturity Date | Interest Rate (3) | Principal Amount (4) |
Cost | Fair Value (5) | Footnotes | |||||||||||||||
| Debt Securities- United States, Continued | ||||||||||||||||||||||
| Green Technology | ||||||||||||||||||||||
| Commonwealth Fusion Systems, LLC | Equipment Financing | July 1, 2030 | Fixed interest rate 13.2%; EOT 10.6% | $ | 3,437 | $ | 3,542 | $ | 3,559 | |||||||||||||
| Equipment Financing | July 1, 2030 | Fixed interest rate 13.0%; EOT 11.1% | 1,188 | 1,278 | 1,261 | |||||||||||||||||
| Total Commonwealth Fusion Systems, LLC | $ | 4,625 | $ | 4,820 | $ | 4,820 | ||||||||||||||||
| Crusoe Energy Systems LLC | Equipment Financing | March 1, 2029 | Fixed interest rate 12.7%; EOT 0.0% | $ | 1,222 | $ | 1,212 | $ | 1,242 | |||||||||||||
| Electric Hydrogen Co. | Equipment Financing | January 1, 2029 | Fixed interest rate 12.6%; EOT 16.3% | $ | 931 | $ | 971 | $ | 966 | |||||||||||||
| Equipment Financing | October 1, 2028 | Fixed interest rate 12.5%; EOT 15.6% | 571 | 580 | 582 | |||||||||||||||||
| Equipment Financing | January 1, 2029 | Fixed interest rate 12.6%; EOT 16.3% | 1,135 | 1,236 | 1,197 | |||||||||||||||||
| Equipment Financing | October 1, 2028 | Fixed interest rate 11.9%; EOT 15.0% | 136 | 136 | 136 | |||||||||||||||||
| Total Electric Hydrogen Co. | $ | 2,773 | $ | 2,923 | $ | 2,881 | ||||||||||||||||
| Form Energy Inc. | Equipment Financing | November 1, 2027 | Fixed interest rate 12.7%; EOT 3.1% | $ | 2,274 | $ | 2,231 | $ | 2,231 | |||||||||||||
| Equipment Financing | January 1, 2028 | Fixed interest rate 12.5%; EOT 3.0% | 600 | 586 | 586 | |||||||||||||||||
| Total Form Energy Inc. | $ | 2,874 | $ | 2,817 | $ | 2,817 | ||||||||||||||||
| Sub-Total: Green Technology (20.9)* | $ | 11,494 | $ | 11,772 | $ | 11,760 | ||||||||||||||||
| Healthcare Technology | ||||||||||||||||||||||
| RXAnte, Inc. | Secured Loan | December 1, 2027 | Variable interest rate Prime + 4.5% or Floor rate 10.0%+PIK Fixed Interest Rate 1.5%; EOT 3.4% | $ | 765 | $ | 788 | $ | 773 | (6)(7) | ||||||||||||
| Secured Loan | December 1, 2027 | Variable interest rate Prime + 4.5% or Floor rate 10.0%+PIK Fixed Interest Rate 1.5%; EOT 3.4% | 247 | 258 | 255 | (6)(7) | ||||||||||||||||
| Secured Loan | December 1, 2027 | Variable interest rate Prime + 4.5% or Floor rate 10.0%+PIK Fixed Interest Rate 1.5%; EOT 3.5% | 251 | 258 | 257 | (6)(7) | ||||||||||||||||
| Secured Loan | December 1, 2027 | Variable interest rate Prime + 4.5% or Floor rate 10.0%+PIK Fixed Interest Rate 1.5%; EOT 3.5% | 247 | 246 | 253 | (6)(7) | ||||||||||||||||
| Total RXAnte, Inc. | $ | 1,510 | $ | 1,550 | $ | 1,538 | ||||||||||||||||
| Sub-Total: Healthcare Technology (2.7%)* | $ | 1,510 | $ | 1,550 | $ | 1,538 | ||||||||||||||||
| Marketing, Media, and Entertainment | ||||||||||||||||||||||
| Vox Media Holdings, Inc. | Secured Loan | November 1, 2027 | Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5% | $ | 1,494 | $ | 1,532 | $ | 1,538 | (6) | ||||||||||||
| Secured Loan | January 1, 2028 | Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5% | 749 | 766 | 767 | (6) | ||||||||||||||||
| Total Vox Media Holdings, Inc. | $ | 2,243 | $ | 2,298 | $ | 2,305 | ||||||||||||||||
| Sub-Total: Marketing, Media, and Entertainment (4.1%)* | $ | 2,243 | $ | 2,298 | $ | 2,305 | ||||||||||||||||
F-11
EPT 16 LLC
Consolidated Schedule of Investments
December 31, 2024
(In thousands)
| Portfolio Company (1) | Type
of Investment (2) |
Maturity Date | Interest Rate (3) | Principal Amount (4) |
Cost | Fair Value (5) | Footnotes | |||||||||||||||
| Debt Securities- United States, Continued | ||||||||||||||||||||||
| Medical Devices | ||||||||||||||||||||||
| Apiject Holdings, Inc. | Equipment Financing | July 1, 2028 | Fixed interest rate 12.6%; EOT 8.2% | $ | 1,139 | $ | 1,153 | $ | 1,148 | |||||||||||||
| Equipment Financing | October 1, 2028 | Fixed interest rate 12.7%; EOT 7.8% | 565 | 556 | 560 | |||||||||||||||||
| Total Apiject Holdings, Inc. | $ | 1,704 | $ | 1,709 | $ | 1,708 | ||||||||||||||||
| Elucent Medical, Inc. | Secured Loan | November 30, 2029 | Variable interest rate PRIME + 3.8% or Floor rate 11.3%; EOT 3.3% | $ | 900 | $ | 882 | $ | 882 | (6) | ||||||||||||
| Lightforce Orthodontics, Inc. | Secured Loan | August 6, 2029 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0% | $ | 1,800 | $ | 1,775 | $ | 1,791 | (6) | ||||||||||||
| Secured Loan | August 6, 2029 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0% | 300 | 296 | 298 | (6) | ||||||||||||||||
| Total Lightforce Orthodontics, Inc. | $ | 2,100 | $ | 2,071 | $ | 2,089 | ||||||||||||||||
| Restor3d, Inc. | Secured Loan | July 4, 2028 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.3% | $ | 765 | $ | 768 | $ | 766 | (6) | ||||||||||||
| Vital Connect, Inc. | Secured Loan | July 3, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0% | $ | 2,100 | $ | 2,088 | $ | 2,107 | (6) | ||||||||||||
| Sub-Total: Medical Devices (13.4%)* | $ | 7,569 | $ | 7,518 | $ | 7,552 | ||||||||||||||||
| Other Healthcare Services | ||||||||||||||||||||||
| Cellares Corporation | Equipment Financing | September 1, 2029 | Fixed interest rate 12.0%; EOT 4.7% | $ | 285 | $ | 286 | $ | 291 | |||||||||||||
| Secured Loan | February 1, 2027 | Variable interest rate Prime + 3.3% or Floor rate 11.8%; EOT 4.0% | 3,000 | 2,962 | 3,014 | (6) | ||||||||||||||||
| Total Cellares Corporation | $ | 3,285 | $ | 3,248 | $ | 3,305 | ||||||||||||||||
| Upward Health, Inc. | Secured Loan | September 1, 2029 | Variable interest rate Prime + 4.3% or Floor rate 12.8%; EOT 3.0% | $ | 500 | $ | 485 | $ | 496 | (6) | ||||||||||||
| Sub-Total: Other Healthcare Services (6.8%)* | $ | 3,785 | $ | 3,733 | $ | 3,801 | ||||||||||||||||
F-12
EPT 16 LLC
Consolidated Schedule of Investments
December 31, 2024
(In thousands)
| Portfolio Company (1) | Type
of Investment (2) |
Maturity Date | Interest Rate (3) | Principal Amount (4) |
Cost | Fair Value (5) | Footnotes | |||||||||||||||
| Debt Securities- United States, Continued | ||||||||||||||||||||||
| SAAS | ||||||||||||||||||||||
| Eyelit Technologies, Inc. | Secured Loan | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 5.8% or Floor rate 0.0%; EOT 0.0% | $ | 500 | $ | 490 | $ | 490 | (6) | ||||||||||||
| Secured Loan | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 5.8% or Floor rate 0.0%; EOT 0.0% | 880 | 863 | 863 | (6) | ||||||||||||||||
| Total Eyelit Technologies, Inc. | $ | 1,380 | $ | 1,353 | $ | 1,353 | ||||||||||||||||
| Hometown Ticketing, Inc. | Secured Loan | November 25, 2029 | Variable interest rate SOFR 3 Month Term + 7.7% or Floor rate 5.5%; EOT 0.0% | $ | 1,590 | $ | 1,559 | $ | 1,559 | (6) | ||||||||||||
| ServiceTrade, Inc. | Secured Loan | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3% or Floor rate 0.0%; EOT 0.0% | $ | 1,500 | $ | 1,476 | $ | 1,515 | (6) | ||||||||||||
| Silk Technologies, Inc. | Secured Loan | December 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.3%; EOT 1.5% | $ | 1,200 | $ | 1,168 | $ | 1,168 | (6) | ||||||||||||
| SOCi, Inc. | Secured Loan | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.9% or Floor rate 0.0%; EOT 0.0% | $ | 2,304 | $ | 2,255 | $ | 2,255 | (6) | ||||||||||||
| Secured Loan | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.8% or Floor rate 0.0%; EOT 0.0% | 210 | 205 | 205 | (6) | ||||||||||||||||
| Total SOCi, Inc. | $ | 2,514 | $ | 2,460 | $ | 2,460 | ||||||||||||||||
| Steno Agency, Inc. | Secured Loan | July 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5% | $ | 510 | $ | 505 | $ | 511 | (6) | ||||||||||||
| Sub-Total: SAAS (15.2%)* | $ | 8,694 | $ | 8,521 | $ | 8,566 | ||||||||||||||||
| Space Technology | ||||||||||||||||||||||
| Astranis Space Technologies Corp. | Equipment Financing | November 1, 2026 | Fixed interest rate 12.1%; EOT 7.8% | $ | 996 | $ | 1,092 | $ | 1,076 | |||||||||||||
| Equipment Financing | April 1, 2028 | Fixed interest rate 12.4%; EOT 5.8% | 1,040 | 991 | 1,006 | |||||||||||||||||
| Equipment Financing | October 1, 2027 | Fixed interest rate 12.6%; EOT 4.2% | 257 | 245 | 248 | |||||||||||||||||
| Total Astranis Space Technologies Corp. | $ | 2,293 | $ | 2,328 | $ | 2,330 | ||||||||||||||||
| Hadrian Automation Inc. | Equipment Financing | December 1, 2026 | Fixed interest rate 16.4%; EOT 0.0% | $ | 352 | $ | 366 | $ | 365 | |||||||||||||
| Equipment Financing | March 1, 2027 | Fixed interest rate 15.7%; EOT 0.0% | 1,130 | 1,170 | 1,164 | |||||||||||||||||
| Equipment Financing | September 1, 2027 | Fixed interest rate 17.7%; EOT 0.0% | 612 | 628 | 636 | |||||||||||||||||
| Equipment Financing | June 1, 2028 | Fixed interest rate 17.6%; EOT 0.0% | 1,664 | 1,696 | 1,709 | |||||||||||||||||
| Total Hadrian Automation Inc. | $ | 3,758 | $ | 3,860 | $ | 3,874 | ||||||||||||||||
| Impulse Space, Inc. | Equipment Financing | July 1, 2027 | Fixed interest rate 12.7%; EOT 3.4% | $ | 286 | $ | 288 | $ | 289 | |||||||||||||
| Equipment Financing | October 1, 2027 | Fixed interest rate 12.5%; EOT 3.2% | 277 | 273 | 279 | |||||||||||||||||
| Equipment Financing | January 1, 2028 | Fixed interest rate 12.9%; EOT 3.0% | 269 | 268 | 268 | |||||||||||||||||
| Total Impulse Space, Inc. | $ | 832 | $ | 829 | $ | 836 | ||||||||||||||||
| Kymeta Corporation | Secured Loan | August 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 3.0% | $ | 600 | $ | 576 | $ | 591 | (6) | ||||||||||||
| Slingshot Aerospace, Inc. | Secured Loan | August 1, 2029 | Variable interest rate Prime + 5.5% or Floor rate 14.0%; EOT 3.0% | $ | 1,800 | $ | 1,765 | $ | 1,804 | (6) | ||||||||||||
| Sub-Total: Space Technology (16.8%)* | $ | 9,283 | $ | 9,358 | $ | 9,435 | ||||||||||||||||
| Total: Debt Securities- United States (113.8%)* | $ | 63,530 | $ | 63,698 | $ | 64,083 | ||||||||||||||||
F-13
EPT 16 LLC
Consolidated Schedule of Investments
December 31, 2024
(In thousands)
| Portfolio Company (1) | Type
of Investment (2) |
Maturity Date | Interest Rate (3) | Principal Amount (4) |
Cost | Fair Value (5) | Footnotes | |||||||||||||||
| Debt Securities- Europe | ||||||||||||||||||||||
| Other Healthcare Services | ||||||||||||||||||||||
| Zandivio PLC | Secured Loan | May 1, 2029 | Variable interest rate PRIME + 5.3% or Floor rate 13.8%; EOT 2.5% | $ | 1,800 | $ | 1,751 | $ | 1,751 | (6) | ||||||||||||
| Sub-Total: Other Healthcare Services (3.1%)* | $ | 1,800 | $ | 1,751 | $ | 1,751 | ||||||||||||||||
| Total: Debt Securities- Europe (3.1%)* | $ | 1,800 | $ | 1,751 | $ | 1,751 | ||||||||||||||||
| Total: Debt Securities- (116.9%)* | $ | 65,330 | $ | 65,449 | $ | 65,834 | ||||||||||||||||
F-14
EPT 16 LLC
Consolidated Schedule of Investments
December 31, 2024
(In thousands, except share and per share data)
| Portfolio Company (1) | Type
of Investment (2)(8) |
Investment Date | Expiration Date | Series | Shares | Strike Price |
Cost | Fair Value (5) | Footnotes | |||||||||||||||||||
| Warrant Investments- United States | ||||||||||||||||||||||||||||
| Connectivity | ||||||||||||||||||||||||||||
| Tarana Wireless, Inc. | Warrant | November 19, 2024 | September 23, 2034 | Common Stock | 169,859 | $ | 0.51 | $ | 56 | $ | 59 | |||||||||||||||||
| Sub-Total: Connectivity (0.1%)* | $ | 56 | $ | 59 | ||||||||||||||||||||||||
| Consumer Products & Services | ||||||||||||||||||||||||||||
| Ogee, Inc. | Warrant | November 25, 2024 | February 14, 2033 | Preferred Series A-3 | 15,553 | $ | 0.68 | $ | 8 | $ | 19 | |||||||||||||||||
| Warrant | November 25, 2024 | September 29, 2033 | Preferred Series A-3 | 15,553 | $ | 0.68 | 8 | 19 | ||||||||||||||||||||
| Warrant | November 25, 2024 | August 1, 2034 | Preferred Series A-3 | 15,553 | $ | 0.68 | 8 | 19 | ||||||||||||||||||||
| Total Ogee, Inc. | $ | 24 | $ | 57 | ||||||||||||||||||||||||
| Whoop, Inc. | Warrant | June 28, 2024 | May 17, 2033 | Common Stock | 93,745 | $ | 0.43 | $ | 76 | $ | 89 | |||||||||||||||||
| Sub-Total: Consumer Products & Services (0.3%)* | $ | 100 | $ | 146 | ||||||||||||||||||||||||
| Finance and Insurance | ||||||||||||||||||||||||||||
| Beam Technologies, Inc. | Warrant | November 19, 2024 | August 30, 2034 | Common Stock | 3,606 | $ | 17.28 | $ | 46 | $ | 44 | |||||||||||||||||
| Centivo Corporation | Warrant | November 19, 2024 | July 31, 2034 | Common Stock | 21,488 | $ | 0.76 | $ | 33 | $ | 49 | |||||||||||||||||
| Empower Financial, Inc. | Warrant | June 28, 2024 | October 13, 2033 | Common Stock | 13,503 | $ | 1.43 | $ | 51 | $ | 51 | |||||||||||||||||
| Gravie, Inc. | Warrant | November 19, 2024 | June 4, 2034 | Common Stock | 7,903 | $ | 2.68 | $ | 16 | $ | 16 | |||||||||||||||||
| Under Technologies, Inc. | Warrant | November 19, 2024 | May 3, 2034 | Common Stock | 6,173 | $ | 2.90 | $ | 17 | $ | 16 | |||||||||||||||||
| Wisetack, Inc. | Warrant | November 14, 2024 | November 14, 2034 | Common Stock | 8,234 | $ | 1.58 | $ | 8 | $ | 8 | |||||||||||||||||
| Sub-Total: Finance and Insurance (0.3%)* | $ | 171 | $ | 184 | ||||||||||||||||||||||||
| Food and Agriculture Technologies | ||||||||||||||||||||||||||||
| DrinkPak, LLC | Warrant | June 28, 2024 | February 17, 2033 | Common Stock | 1,608 | $ | 18.89 | $ | 69 | $ | 40 | |||||||||||||||||
| Sub-Total: Food and Agriculture Technologies (0.1%)* | $ | 69 | $ | 40 | ||||||||||||||||||||||||
| Green Technology | ||||||||||||||||||||||||||||
| Form Energy Inc. | Warrant | November 19, 2024 | October 21, 2034 | Common Stock | 6,338 | $ | 8.03 | $ | 59 | $ | 57 | |||||||||||||||||
| Sub-Total: Green Technology (0.1%)* | $ | 59 | $ | 57 | ||||||||||||||||||||||||
| Healthcare Technology | ||||||||||||||||||||||||||||
| RXAnte, Inc. | Warrant | June 28, 2024 | November 21, 2032 | Preferred A | 1,483 | $ | 10.00 | $ | 11 | $ | 11 | |||||||||||||||||
| Warrant | June 28, 2024 | November 21, 2032 | Preferred A | 482 | $ | 10.00 | 6 | 4 | ||||||||||||||||||||
| Warrant | June 28, 2024 | November 21, 2032 | Preferred A | 494 | $ | 10.00 | 5 | 4 | ||||||||||||||||||||
| Total RXAnte, Inc. | $ | 22 | $ | 19 | ||||||||||||||||||||||||
| Sub-Total: Healthcare Technology (0.0%)* | $ | 22 | $ | 19 | ||||||||||||||||||||||||
F-15
EPT 16 LLC
Consolidated Schedule of Investments
December 31, 2024
(In thousands, except share and per share data)
| Portfolio Company (1) | Type
of Investment (2)(8) |
Investment Date | Expiration Date | Series | Shares | Strike Price |
Cost | Fair Value (5) | Footnotes | |||||||||||||||||||
| Warrant Investments- United States, Continued | ||||||||||||||||||||||||||||
| Medical Devices | ||||||||||||||||||||||||||||
| Apiject Holdings, Inc. | Warrant | November 19, 2024 | June 24, 2034 | Common Stock | 63,068 | $ | 0.99 | $ | 35 | $ | 24 | |||||||||||||||||
| Elucent Medical, Inc. | Warrant | November 19, 2024 | October 31, 2034 | Preferred Series C-2 | 120,603 | $ | 0.30 | $ | 11 | $ | 13 | |||||||||||||||||
| Lightforce Orthodontics, Inc. | Warrant | November 19, 2024 | August 6, 2034 | Preferred Series D | 4,663 | $ | 18.01 | $ | 17 | $ | 18 | |||||||||||||||||
| Restor3d, Inc. | Warrant | November 19, 2024 | June 4, 2034 | Preferred Series A | 6,108 | $ | 5.01 | $ | 5 | $ | 5 | |||||||||||||||||
| Sub-Total: Medical Devices (0.1%)* | $ | 68 | $ | 60 | ||||||||||||||||||||||||
| Other Healthcare Services | ||||||||||||||||||||||||||||
| Cellares Corporation | Warrant | November 19, 2024 | August 2, 2034 | Common Stock | 15,566 | $ | 4.77 | $ | 54 | $ | 52 | |||||||||||||||||
| Upward Health, Inc. | Warrant | November 19, 2024 | August 6, 2034 | Preferred Class A Common Stock | 64,948 | $ | 0.28 | $ | 21 | $ | 22 | |||||||||||||||||
| Sub-Total: Other Healthcare Services (0.1%)* | $ | 75 | $ | 74 | ||||||||||||||||||||||||
| SAAS | ||||||||||||||||||||||||||||
| Silk Technologies, Inc. | Warrant | November 4, 2024 | November 4, 2034 | Common Stock | 15,167 | $ | 1.98 | $ | 32 | $ | 31 | |||||||||||||||||
| Steno Agency, Inc. | Warrant | November 19, 2024 | June 21, 2034 | Common Stock | 7,612 | $ | 1.98 | $ | 18 | $ | 20 | |||||||||||||||||
| Sub-total: SAAS (0.1%)* | $ | 50 | $ | 51 | ||||||||||||||||||||||||
| Space Technology | ||||||||||||||||||||||||||||
| Astranis Space Technologies Corp. | Warrant | June 28, 2024 | April 13, 2033 | Common Stock | 11,203 | $ | 7.89 | $ | 39 | $ | 36 | |||||||||||||||||
| Warrant | November 19, 2024 | September 27, 2034 | Common Stock | 14,930 | $ | 2.27 | 66 | 65 | ||||||||||||||||||||
| Total Astranis Space Technologies Corp. | $ | 105 | $ | 101 | ||||||||||||||||||||||||
| Hermeus Corporation | Warrant | June 28, 2024 | August 9, 2032 | Common Stock | 9,338 | $ | 6.24 | $ | 21 | $ | 23 | |||||||||||||||||
| Impulse Space, Inc. | Warrant | November 19, 2024 | June 18, 2034 | Common Stock | 3,222 | $ | 1.91 | $ | 27 | $ | 28 | |||||||||||||||||
| Kymeta Corporation | Warrant | November 19, 2024 | July 3, 2034 | Common Stock | 303,449 | $ | 0.11 | $ | 22 | $ | 27 | |||||||||||||||||
| Slingshot Aerospace, Inc. | Warrant | November 19, 2024 | July 12, 2034 | Common Stock | 24,943 | $ | 0.46 | $ | 30 | $ | 30 | |||||||||||||||||
| Sub-Total: Space Technology (0.4%)* | $ | 205 | $ | 209 | ||||||||||||||||||||||||
| Total: Warrant Investments- United States (1.6%)* | $ | 875 | $ | 899 | ||||||||||||||||||||||||
F-16
EPT 16 LLC
Consolidated Schedule of Investments
December 31, 2024
(In thousands, except share and per share data)
| Portfolio Company (1) | Type
of Investment (2)(8) |
Investment Date | Expiration Date | Series | Shares | Strike Price |
Cost | Fair Value (5) | Footnotes | |||||||||||||||||||
| Warrant Investments- Europe | ||||||||||||||||||||||||||||
| Other Healthcare Services | ||||||||||||||||||||||||||||
| Zandivio PLC | Warrant | November 19, 2024 | October 29, 2034 | Common Stock | 8,428 | $ | 0.01 | $ | 49 | $ | 54 | |||||||||||||||||
| Sub-Total: Other Healthcare Services (0.1%)* | $ | 49 | $ | 54 | ||||||||||||||||||||||||
| Total: Warrant Investments- Europe (0.1%)* | $ | 49 | $ | 54 | ||||||||||||||||||||||||
| Total: Warrant Investments- (1.7%)* | $ | 924 | $ | 953 | ||||||||||||||||||||||||
F-17
EPT 16 LLC
Consolidated Schedule of Investments
December 31, 2024
(In thousands, except share and per share data)
| Portfolio Company (1) | Type
of Investment (2)(8) |
Investment Date | Shares/Principal | Series | Cost | Fair Value (5) | Footnotes | |||||||||||||||
| Equity Investments- United States | ||||||||||||||||||||||
| Finance and Insurance | ||||||||||||||||||||||
| Centivo Corporation | Equity | December 20, 2024 | 17,119 | Preferred Series B-1 | $ | 50 | $ | 49 | ||||||||||||||
| Sub-Total: Finance and Insurance (0.1%)* | $ | 50 | $ | 49 | ||||||||||||||||||
| Green Technology | ||||||||||||||||||||||
| Crusoe Energy Systems LLC | Equity | November 6, 2024 | 1,713 | Preferred Series D-1 | $ | 50 | $ | 50 | ||||||||||||||
| Sub-Total: Green Technology (0.1%)* | $ | 50 | $ | 50 | ||||||||||||||||||
| Total: Equity Investments- United States (0.2%)* | $ | 100 | $ | 99 | ||||||||||||||||||
| Total Investment in Securities (118.8%)* | $ | 66,473 | $ | 66,886 |
| (1) | All portfolio companies are located in North America or Europe. As of December 31, 2024, EPT 16 LLC (the “Fund”) had one foreign domiciled portfolio companies based in Europe. In total, this foreign domiciled portfolio investment represent 3.2% of total net asset value based on fair value. |
| (2) | All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted. |
| (3) | Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term (“EOT”) payment, or additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair value, generally subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the term of the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Fund’s current debt securities. |
| (4) | Principal is net of repayments, if any, as per the terms of the debt instrument’s contract. |
| (5) | All investments were valued at fair value as determined in good faith by EPT 16 LLC using Level 3 inputs. |
| (6) | The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. The Prime rate was 7.5% as of December 31, 2024. |
| (7) | Interest on this loan includes a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is recorded on an accrual basis to the extent such amounts are expected to be collected. |
| (8) | All of the company's debt securities are pledged as collateral supporting amounts outstanding under the Company's credit facility with KeyBank, National Association (the “KeyBank Credit Facility”), except as noted. See “Note 4 – Credit Facility” for more information. |
| * | Represents % of Members' Capital. |
F-18
EPT 16 LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Organization and Basis of Presentation
On May 3, 2024, EPT 16 LLC (“EPT 16” or the “Fund”) was formed as a Delaware limited liability company. EPT 16 commenced its operations on June 28, 2024 and is governed by an amended and restated LLC agreement (the “LLC Agreement”) entered into by and among Trinity Capital Inc. (“Trinity Capital” or “TRIN”) and EPCM Holdings LLC (the “Class A Member”). Pursuant to the LLC Agreement, EPT 16’s purpose is to acquire, hold and, as applicable, dispose of investments, including certain investments originated by Trinity Capital.
On June 28, 2024, EPT 16 entered into an Investment Advisory Agreement (the “Advisory Agreement”) between EPT 16 and Trinity Capital Adviser LLC (the “Manager”), a wholly owned subsidiary of Trinity Capital. The Advisory Agreement specifies that the Manager will act as the investment adviser to the Fund and manage the investment and reinvestment decisions of the assets of the Fund. Notwithstanding the foregoing, the Class A Member shall be required to approve the proposed allocation of each investment to the Fund prior to the Fund making such investment, which approval shall not be unreasonably withheld so long as the proposed allocation is in accordance with the Manager’s investment allocation policy as provided to the Class A Member. Pursuant to the Advisory Agreement, the Manager will earn certain base management and incentive fees in exchange for providing advisory services to EPT 16 as discussed in “Note 6 – Related Party Transactions”.
EPT 16 has two members (collectively, the “Members”), TRIN and the Class A Member, and is managed by the Manager. TRIN and the Class A Member’s initial capital commitments to EPT 16 were $10.0 million and $50.0 million, respectively.
On June 28, 2024, EPT 16 entered into an Administrative Services Agreement (the “Administration Agreement”) between EPT 16 and an administrative agent (the “Administrator”). Pursuant to the Administration Agreement, the Administrator provides the Fund with office facilities, equipment, clerical, bookkeeping, and record keeping services at such facilities and such other services as the Administrator from time to time determine to be necessary or useful to perform its obligations under the Administration Agreement.
EPT 16 holds certain assets through its wholly- owned subsidiary, EPT SPV 16 SUB (US) LLC (the “SPV”), to secure the KeyBank Credit Facility as discussed in “Note 4 – Credit Facility”. EPT 16 and the SPV are collectively referred to herein as the “Fund.”
2. Significant Accounting Policies
Basis of Presentation
The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Fund is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”). U.S. GAAP for an investment company requires investments to be recorded at their estimated fair value. The carrying value for all other assets and liabilities approximates their fair value.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ materially from these estimates.
F-19
Consolidation
The consolidated financial statements include EPT 16 and its wholly owned subsidiary, the SPV. All intercompany accounts and transactions have been eliminated in consolidation.
Investment Transactions and Investment Income
Loan originations are recorded on the date of the legally binding commitment. Realized gains or losses are recorded using the specific identification method as the difference between the net proceeds received, excluding prepayment fees, if any, and the amortized cost basis of the investment without regard to unrealized gains or losses previously recognized, and include investments written off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment fair values as of the last business day of the reporting period and also includes the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.
The Fund recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Fund may also be entitled to an end-of-term (“EOT”) fee. EOT fees to be paid at the termination of the debt agreements are accreted into interest income over the contractual life of the debt based on the effective yield method. The EOT payments receivable is included as a component of the cost basis of the Fund’s current debt securities. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, the acceleration of the unaccreted OID and EOT fees is recognized as interest income.
The Fund has a limited number of debt investments in its portfolio that contain a payment- in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Fund will generally cease accruing PIK interest if there is insufficient value to support the accrual or management does not expect the portfolio company to be able to pay all principal and interest due. The Fund recorded $17,900 of PIK interest income during the period ended December 31, 2024.
Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are amortized into interest income over the contractual life of the loan. The Fund recognizes nonrecurring fees and additional OID and EOT fees received in consideration for contract modifications commencing in the year relating to the specific modification.
Fee Income
The Fund recognizes one-time fee income, including, but not limited to prepayment penalties and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company pays off their outstanding indebtedness prior to the scheduled maturity.
Non-Accrual Policy
When a debt security becomes 90 days or more past due, or if management otherwise does not expect that principal, interest, and other obligations due will be collected in full, the Fund will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or the Fund believes the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, the Fund may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection. As of December 31, 2024, there were no investments on non-accrual status.
F-20
Net Realized Gains / (Losses)
Realized gains / (losses) are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written off during the period net of recoveries and realized gains or losses from in- kind redemptions. Net proceeds exclude any prepayment penalties, exit fees, and OID and EOT acceleration. Prepayment penalties and exit fees received at the time of sale or redemption are included in fee income on the Consolidated Statements of Operations. OID and EOT acceleration is included in interest income on the Consolidated Statements of Operations.
Cash and Cash Equivalents
Cash and cash equivalents consist of funds deposited with financial institutions and short-term (original maturity of three months or less) liquid investments in money market deposit accounts. Cash equivalents are classified as Level 1 assets and are valued using the net asset value (“NAV”) per share of the money market fund. As of December 31, 2024, cash and cash equivalents consisted of $2.2 million. Cash held in demand deposit accounts may exceed the FDIC insured limit and therefore is subject to credit risk. All of the Fund’s cash deposits are held at large, established, high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote.
Interest Receivable
Interest receivable consists of interest due from the Fund’s portfolio companies as of the balance sheet date.
Security Deposits
Security deposits are collected upon funding equipment financings and are applied in lieu of regular payments at the end of the term.
Deferred Financing Costs
The Fund records costs related to the issuance of debt obligations as deferred debt financing costs. These costs are deferred and amortized using the straight-line method over the stated maturity life of the obligations. Debt financing costs related to the KeyBank Credit Facility are recorded as a separate asset on the Fund’s Consolidated Statement of Assets and Liabilities.
Income Taxes
Both EPT 16 and SPV are not subject to U.S. Federal income taxes. Each Member is individually liable for income taxes, if any, on its share of the Fund’s net taxable income. Each Member is required for income tax purposes to take into account its distributive share of all items of the Fund’s income, gain, loss, deduction, and other items for such taxable year of the Fund. The tax basis income and losses may differ from the income and losses in the Statement of Operations, which is prepared in accordance with U.S. GAAP.
The Fund determines whether a tax position is more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For tax positions meeting the more likely than not threshold, any tax amount recognized in the financial statements is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. There were no uncertain tax positions as of December 31, 2024.
F-21
The following table sets forth the tax cost basis and the estimated aggregate gross unrealized appreciation and depreciation from investments for federal income tax purposes as of and for the years ended December 31, 2024 (in thousands):
| December 31, 2024 | ||||
| Tax Cost of Investments | $ | 66,473 | ||
| December 31, 2024 | ||||
| Unrealized appreciation | $ | 609 | ||
| Unrealized depreciation | (196 | ) | ||
| Net change in unrealized appreciation from investments | $ | 413 | ||
Allocation to Members
To the extent that the Fund has income (loss) net of expenses accrued in accordance with the LLC Agreement, net realized gain (loss) and net change in unrealized appreciation (depreciation) on investments, calculated in accordance with U.S. GAAP, the Fund will allocate such amounts among the Members pro rata based on their respective membership interests in accordance with the LLC Agreement.
Capital Calls and Distributions to Members
Capital contributions are made by the Members on a pro rata basis based on their respective capital commitments and recorded on the effective date of the contributions. To the extent that the Fund has taxable income available, the Administrator may determine to make a distribution to Members on a pro rata basis based on their respective membership interests to members are recorded on the record date. The amount to be distributed is determined by the Administrator and is generally based upon the taxable earnings and available cash. Such payments to Members relating to their membership interests are reflected as distributions.
Recent Accounting Pronouncements
The Fund assessed recent accounting pronouncements released by the FASB and noted that none have a material impact to the consolidated financial statements as of December 31, 2024.
Note 3. Investment Valuation
The Fund applies the valuation policy that is consistent with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). Consistent with the valuation policy, the Fund evaluates the source of inputs, including any markets in which its investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value. When a security is valued based on prices provided by reputable dealers or pricing services (that is, broker quotes), the Fund subjects those prices to various criteria in making the determination as to whether a particular investment would qualify for classification as a Level 2 or Level 3 investment. For example, the Fund reviews pricing methodologies provided by dealers or pricing services in order to determine if observable market information is being used, versus unobservable inputs. Some additional factors considered include the number of prices obtained as well as an assessment as to their quality. Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur.
The Fund has engaged independent valuation firms to provide the Fund with valuation assistance with respect to its investments on a discretionary basis. Specifically, on a quarterly basis, the Fund identifies portfolio investments with respect to which an independent valuation firm assists in valuing such investments. The Fund selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.
F-22
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The guidance establishes three levels of the fair value hierarchy as follows:
Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Fund has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).
Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.
Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the investment.
Given the nature of lending to venture capital-backed growth-stage companies, 100%, based on fair value, of the Fund’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanged. The Fund uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis, and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Fund’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.
Debt Securities
The debt securities identified on the Consolidated Condensed Schedule of Investments are secured loans and equipment financings made to growth-stage companies. For portfolio investments in debt securities for which the Fund has determined that third-party quotes or other independent pricing are not available, the Fund generally estimates the fair value based on the assumptions that hypothetical market participants would use to value the investment in a current hypothetical sale using an income approach.
In its application of the income approach to determine the fair value of debt securities, the Fund bases its assessment of fair value on projections of the discounted future free cash flows that the security will likely generate, including analyzing the discounted cash flows of interest and principal amounts for the security, as set forth in the associated loan and equipment financing agreements, as well as market yields and the financial position and credit risk of the portfolio company (the “Hypothetical Market Yield Method”). The discount rate applied to the future cash flows of the security is based on the calibrated yield implied by the terms of the Fund’s investment adjusted for changes in market yields and performance of the subject company. The Fund’s estimate of the expected repayment date of its loans and equipment financings securities is either the maturity date of the instrument or the anticipated pre-payment date, depending on the facts and circumstances. The Hypothetical Market Yield Method also considers changes in leverage levels, credit quality, portfolio company performance, market yield movements, and other factors. If there is deterioration in credit quality or if a security is in workout status, the Fund may consider other factors in determining the fair value of the security, including, but not limited to, the value attributable to the security from the enterprise value of the portfolio company or the proceeds that would most likely be received in a liquidation analysis.
Equity Securities and Warrants
Often the Fund is issued warrants by issuers as yield enhancements. These warrants are recorded as assets at estimated fair value on the grant date. The Fund determines the cost basis of the warrants or other equity securities received based upon their respective fair values on the date of receipt in proportion to the total fair value of the debt and warrants or other equity securities received. Depending on the facts and circumstances, the Fund generally utilizes a combination of one or several forms of the market approach and contingent claim analyses (a form of option analysis) to estimate the fair value of the securities as of the measurement date and determines the cost basis using a relative fair value methodology. As part of its application of the market approach, the Fund estimates the enterprise value of a portfolio company utilizing customary pricing multiples, based on the development stage of the underlying issuers, or other appropriate valuation methods, such as considering recent transactions in the equity securities of the portfolio company or third-party valuations that are assessed to be indicative of fair value of the respective portfolio company.
F-23
If appropriate, based on the facts and circumstances, the Fund performs an allocation of the enterprise value to the equity securities utilizing a contingent claim analysis and/or other waterfall calculation by which it allocates the enterprise value across the portfolio company’s securities in order of their preference relative to one another.
Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Fund’s financial instruments, consisting of cash, investments, receivables, payables, and other liabilities, approximate the fair values of such items due to the short-term nature of these instruments.
The following is a summary of the levels within the fair value hierarchy of the Fund’s investment portfolio as of December 31, 2024.
| Fair Value Hierarchy (in thousands) | ||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Secured Loans | $ | — | $ | — | $ | 37,857 | $ | 37,857 | ||||||||
| Equipment Financings | — | — | 27,977 | 27,977 | ||||||||||||
| Warrants | — | — | 953 | 953 | ||||||||||||
| Equity | — | — | 99 | 99 | ||||||||||||
| Total Investments | $ | — | $ | — | $ | 66,886 | $ | 66,886 | ||||||||
The methodology for determining the fair value of the Fund’s investments is discussed in “Note 3 – Investment Valuation”. The following table provides a summary of the significant unobservable inputs used to measure the fair value of the Level 3 portfolio investments as of December 31, 2024. During the period ended December 31, 2024, there were no transfers into and out of Level 3.
| Fair Value as of | ||||||||||||||
| December 31, | ||||||||||||||
| 2024 | Valuation Techniques/ | Unobservable | Weighted | |||||||||||
| Investment Type | (in thousands) | Methodologies | Inputs (1) | Range | Average (2) | |||||||||
| Debt investments | $ | 50,217 | Discounted Cash Flows | Hypothetical Market Yield | 10.5% - 18.9% | 14.7 | % | |||||||
| 15,617 | Cost approximates fair value (5) | n/a | n/a | n/a | ||||||||||
| Equity investments | 99 | Market Approach | Revenue Multiple (3) | n/a | n/a | |||||||||
| Volatility (4) | 45.8% - 83.3% | 64.3 | % | |||||||||||
| Risk-Free Interest Rate | 4.3% - 4.3% | 4.3 | % | |||||||||||
| Estimated Time to Exit (in years) | 2.6 - 2.9 | 2.7 | ||||||||||||
| Warrants | 953 | Market Approach | Revenue Multiple (3) | 0.2x - 34.9x | 7.7 | |||||||||
| Volatility (4) | 35.4% - 100.1% | 63.2 | % | |||||||||||
| Risk-Free Interest Rate | 4.2% - 4.3% | 4.3 | % | |||||||||||
| Estimated Time to Exit (in years) | 1.6 - 3.8 | 2.6 | ||||||||||||
| Total Level 3 Investments | $ | 66,886 | ||||||||||||
F-24
| (1) | The significant unobservable inputs used in the fair value measurement of the Fund’s debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Fund’s equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model (“OPM”) include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing or merger or acquisition events near the measurement date. |
| (2) | Weighted averages are calculated based on the fair value of each investment. |
| (3) | Represents amounts used when the Fund has determined that market participants would use such multiples when pricing the investments. |
| (4) | Represents the range of industry volatility used by market participants when pricing the investment. |
| (5) | Includes debt investments originated within the past three months, for which cost approximates fair value, unless events have occurred during the period that would indicate a different valuation is warranted. |
The following table provides a summary of changes in the fair value of the Funds’s Level 3 debt, including loans and equipment financings (collectively “Debt”), equity and warrant portfolio investments for the year ended December 31, 2024 (in thousands):
| Type of Investment | ||||||||||||||||
| Debt | Equity | Warrants | Total | |||||||||||||
| Fair Value as of June 28, 2024 (commencement of operations) | $ | — | $ | — | $ | — | $ | — | ||||||||
| Purchases, net of deferred fees | 73,602 | 100 | 924 | 74,626 | ||||||||||||
| Proceeds from sales and paydowns | (8,895 | ) | — | — | (8,895 | ) | ||||||||||
| Accretion of OID, EOT, and PIK payments | 424 | — | — | 424 | ||||||||||||
| Net realized gain/(loss) | 318 | — | — | 318 | ||||||||||||
| Net change in unrealized appreciation/(depreciation) | 385 | (1 | ) | 29 | 413 | |||||||||||
| Fair Value as of December 31, 2024 | $ | 65,834 | $ | 99 | $ | 953 | $ | 66,886 | ||||||||
Fair Value of Financial Instruments Carried at Cost
As of December 31, 2024, the carrying value of the KeyBank Credit Facility was approximately $12.4 million. The carrying value of the KeyBank Credit Facility as of December 31, 2024 approximates the fair value, which was estimated using a market yield approach with Level 3 inputs.
Note 4. Credit Facility
KeyBank Credit Facility
On November 12, 2024, SPV, as borrower, and the Manager, as servicer, entered into a senior credit facility (the “KeyBank Credit Facility” or “Credit Facility”) with KeyBank National Association (“KeyBank”) as the administrative and syndication agent and Computershare Trust Company, N.A. as the collateral custodian.
F-25
The KeyBank Credit Facility includes a commitment of $60.0 million from KeyBank and allows the Fund, through the SPV, to borrow up to $60.0 million. Borrowings under the KeyBank Credit Agreement bear interest at a rate equal to the Secured Overnight Financing Rate (“SOFR”) plus 3.00% to 3.30%, subject to the number of eligible loans in the collateral pool and the utilization rate. The KeyBank Credit Facility provides for a variable advance rate of up to 62% on eligible first lien loans and up to 47% on eligible second lien loans.
The KeyBank Credit Facility includes a two-year revolving period and a three-year amortization period and matures on November 12, 2029, unless extended. Such Credit Facility is collateralized by all investment assets held by the SPV. The KeyBank Credit Agreement contains representations and warranties and affirmative and negative covenants customary for secured financings of this type, including certain financial covenants such as a consolidated tangible net worth requirement and a required asset coverage ratio.
The KeyBank Credit Agreement also contains customary events of default (subject to certain grace periods, as applicable), including but not limited to the nonpayment of principal, interest or fees; breach of covenants; inaccuracy of representations or warranties in any material respect; voluntary or involuntary bankruptcy proceedings; and change of control of the borrower without the prior written consent of KeyBank.
For the period from June 28, 2024 to December 31, 2024, the Fund borrowed $12.4 million under the KeyBank Credit Facility and had an annualized weighted average effective interest rate of 14.98%, or 9.73% excluding amortization and custody fees, with a weighted average outstanding balance of $1.4 million.
Note 5. Investment Risk
In the ordinary course of business, the Fund manages a variety of risks, including market risk, credit risk and liquidity risk. The Fund identifies, measures and monitors risk through various control mechanisms, including trading limits and diversifying exposures and activities across a variety of instruments, markets and counterparties.
Market risk is the risk of potential adverse changes to the value of financial instruments because of changes in market conditions, including as a result of changes in the credit quality of a particular issuer, credit spreads, interest rates, and other movements and volatility in security prices or commodities. In particular, the Fund may invest in issuers that are experiencing or have experienced financial or business difficulties (including difficulties resulting from the initiation or prospect of significant litigation or bankruptcy proceedings), which involves significant risks. The Fund manages its exposure to market risk through the use of risk management strategies and various analytical monitoring techniques.
The Fund’s investments are generally comprised of securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.
The Fund’s investments consist of growth-stage companies, many of which have relatively limited operating histories and may experience variation in operating results. Many of these companies conduct business in regulated industries and could be affected by changes in government regulations. Most of the Fund’s borrowers will need additional capital to satisfy their continuing working capital needs and other requirements, and in many instances, to service the interest and principal payments on the debt.
Note 6. Related Party Transactions
As disclosed in “Note 1 – Organization and Basis of Presentation”, the Manager has entered into an investment management agreement with EPT 16 and may enter into additional investment management agreements with other adviser funds in the future, pursuant to which the Manager receives management fees and/or incentive fees based on the assets under management and the performance of the adviser funds, respectively. During the period ended December 31, 2024, no dividend distributions were declared or paid by EPT 16.
F-26
Advisory Fees
Pursuant to the LLC Agreement, the Fund shall pay the Manager advisory fees consisting of two components, a base management fee and an incentive fee. As a reimbursement, the Class A Member is entitled to 50% of all advisory fees paid.
The base management fee shall be calculated and payable quarterly in arrears at an annual rate equal to 1.75% of the average value of the Fund’s managed assets at the end of the two most recently completed calendar quarters. For this purpose, managed assets mean the Fund’s total assets (including assets attributable to the Fund’s use of leverage) minus the sum of the Fund’s accrued liabilities (other than liabilities incurred for the purpose of creating leverage).
The Incentive Fee shall consist of two parts as follows. Under the investment income component (the “Income Incentive Fee”), the Fund shall pay the Manager each quarter an incentive fee with respect to the Fund’s Pre-Incentive Fee Net Investment Income. For this purpose, “Pre-Incentive Fee Net Investment Income” means (a) interest income, dividend income and any other income (including, but not limited to, any other fees, such as commitment, origination, structuring, diligence and consulting fees) accrued during the calendar quarter, minus (b) the Fund’s operating expenses for the quarter (including, but not limited to, the Base Management Fee, expenses payable under the Fund’s administration agreement, any interest expense and/or dividends paid on any issued and outstanding debt or preferred stock but excluding the Fund’s organizational and offering expenses and the Incentive Fee).
Pre-Incentive Fee Net Investment Income includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments payment-in-kind interest and zero- coupon securities), accrued income that the Fund has not yet received in cash. Pre-Incentive Fee Net Investment Income does not include any realized or unrealized capital gains or realized or unrealized losses. Pre-Incentive Fee Net Investment Income, expressed as a rate of return on the value of the Fund’s net assets at the end of the immediately preceding calendar quarter, shall be compared to a “hurdle rate” of 2% (8% annualized) of the Fund’s net asset value per quarter and a “catch up” feature.
Under the capital gains component of the incentive fee (the “Capital Gains Incentive Fee”), the Fund will pay the Manager at the end of each calendar year 20% of the Fund’s aggregate cumulative realized capital gains from the date of its commencement of operations through the end of that year, computed net of all aggregate cumulative realized capital losses and aggregate cumulative unrealized capital depreciation through the end of such year, less the aggregate amount of any previously paid capital gain incentive fees.
GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation.
For the period ended December 31, 2024, the Fund incurred $0.3 million in base management fees and $0.2 million in incentive fees representing Income Incentive Fee and Capital Gains Incentive Fee. As of December 31, 2024, $0.3 million was unpaid and included in management fees payable and $0.2 million was unpaid and included in incentive fees payable. $0.1 million of contingent incentive fees were accrued based on cumulative aggregate unrealized capital appreciation and included in contingent incentive fees payable in the accompanying Consolidated Statement of Assets, Liabilities, and Members’ Capital.
Origination Fee
Pursuant to the LLC Agreement, the Fund shall pay the Manager a fee (the “Origination Fee”) equal to 1% of the funded amount of each loan or equipment financing advance acquired or made by the Fund on, under or with respect to an originated investment purchased by the Fund.
F-27
For the period ended December 31, 2024, the Fund incurred $0.7 million in Origination Fees. As of December 31, 2024, there were no unpaid Origination Fees included in accrued expenses and other liabilities in the accompanying Consolidated Statement of Assets, Liabilities and Members’ Capital.
Allocated Fees and Expenses owed to Related Parties
During the year ended December 31, 2024, the Manager, per the Advisory Agreement, allocated $0.1 million of expenses to the Fund, which, as of December 31, 2024, are owed to the Manager and included in accrued expenses and other liabilities. Additionally, the Fund owes its Members approximately $0.6 million for expenses paid on behalf of the Fund for organization and offering costs, which are included within accrued expenses and other liabilities as of December 31, 2024.
Note 7. Equity Commitments
On June 28, 2024, the Fund entered into the LLC Agreement with its Members, whereby Capital Contributions shall be made by all Members pro rata based on their respective Capital Commitments. As of December 31, 2024, the Members had funded approximately $55.3 million to the Fund and have unfunded commitments of $4.7 million. Income or losses are allocated pro rata to the Members based on capital commitments.
Note 8. Commitment and Contingencies
From time to time, the Fund, Administrator, or Manager, in their capacity per the Administration Agreement, could become party to legal proceedings in the ordinary course of business, including proceedings related to the enforcement of the Fund’s rights under contracts with its portfolio companies. Neither the Fund, nor the Administrator, in such capacity, is currently subject to any material legal proceedings.
In the normal course of business, the Fund entered into contracts which provide a variety of representations and warranties, and that provide general indemnifications. Such contracts included those with certain service providers, brokers and trading counterparties. Any exposure to the Fund under these arrangements is unknown as it would involve future claims that may be made against the Fund; however, based on the Fund’s experience, the risk of loss is remote, and no such claims are expected to occur. As such, the Fund had not accrued any liability in connection with such indemnifications as of December 31, 2024.
Unfunded Commitments
The Fund's commitments and contingencies consist primarily of unused commitments to extend credit in the form of loans or equipment financings to the Fund’s portfolio companies. A portion of these unfunded contractual commitments as of December 31, 2024, are generally dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Fund’s credit agreements contain customary lending provisions that allow the Fund relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the Fund. Since a portion of these commitments may expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Fund’s disclosure of unfunded contractual commitments as of December 31, 2024, includes only those commitments that are available at the request of the portfolio company and are unencumbered by milestones or additional lending provisions.
As of December 31, 2024, the Fund had aggregate unfunded commitments of $2.1 million to two portfolio companies.
F-28
Note 9. Financial Highlights
The following presents financial highlights for the year ended December 31, 2024 (in thousands).
| For the period from June 28, 2024 (commencement of operations) to December 31, 2024 | ||||
| Total return, based on Members’ Capital before incentive fee (1) | 5.6 | % | ||
| Total return, based on Members’ Capital after incentive fee (1) | 4.2 | % | ||
| Ratio/Supplemental Data: | ||||
| Members' Capital, end of period | $ | 56,305 | ||
| Ratio of total expenses before incentive fee to average Members’ Capital (2) | 12.6 | % | ||
| Ratio of total expenses after incentive fee to average Members’ Capital (2) | 14.5 | % | ||
| Ratio of net investment income before incentive fee to average Members’ Capital (2) | 3.6 | % | ||
| Ratio of net investment income after incentive fee to average Members’ Capital (2) | 1.7 | % | ||
| Ratio of interest and credit facility expenses to average net assets | 1.0 | % | ||
| Portfolio turnover rate (3) | 41.9 | % | ||
| Asset coverage ratio (4) | 547.7 | % | ||
| (1) | Total return is calculated based on a time-weighted rate of return methodology. Monthly rates of return for all Members as a whole are geometrically linked to derive the total return reflected above. An individual Member's return may vary from these returns based on the timing of capital transactions. |
| (2) | The expense and net investment income (loss) ratios are annualized and calculated for the Members each taken as a whole. An individual Member's ratios may vary from these ratios based on the timing of capital transactions. |
| (3) | Portfolio turnover rate is calculated using the lesser of year-to-date cash sales/repayments or year-to-date cash purchases over the average of the total investments at fair value. |
| (4) | Based on outstanding debt of $12.4 million as of December 31, 2024. |
Note 10. Subsequent Events
The Fund’s management evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. Except as noted below, there have been no subsequent events that occurred during such period that would require recognition or disclosure.
2028 Series A Notes
On August 1, 2025, the Fund entered into a note purchase agreement (the “2028 Note Purchase Agreement”), governing the issuance of $25.0 million aggregate principal amount of 7.25% Series A Notes due 2028 (the “2028 Series A Notes”) in a transaction exempt from registration under the Securities Act. The 2028 Series A Notes bear interest at the rate of 7.25% per annum, payable semi-annually in arrears on February 1 and August 1 of each year, commencing on February 1, 2026, and will mature on August 1, 2028.
Fund Operation
On August 22, 2025, the Fund made a distribution of approximately $4.9 million to the Members on a pro rata basis according to their respective interests. As of August 28, 2025, the Members had fully funded their capital commitments.
BDC Conversion
On August 28, 2025, the Fund converted into a Delaware statutory trust named Eagle Point Trinity Senior Secured Lending Company in connection with the election to be regulated as a business development company (“BDC”). Members interests in the Fund were converted to 6,013,221 shares of beneficial interest in connection with the BDC conversion. As a BDC, the Fund intends to conduct a continuous private offering of its shares to investors in reliance on exemptions from the registration requirements of the Securities Act, including the exemptions provided by Section 4(a)(2) of the Securities Act and Regulation D and Regulation S (the “Private Offering”).
BDC Operation
Pursuant to the Private Offering, on November 1, 2025, the Fund issued additional shares of beneficial interest resulting in total net proceeds to the Fund of approximately $23,000. The Fund paid its first monthly distribution of $0.084 per share to shareholders of record as of November 28, 2025.
F-29
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Last-Minute Apparel Delivery (2026): Same-Day Options for Outfits, Shoes, and Event Essentials by Consumer365
- Solana Price Prediction: Could SOL Reclaim Its $295 High as AlphaPepe Presale Nears Its Biggest Launch Catalysts?
- IGNITE Social Enterprise Enters Sub-Saharan Africa
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share